Accuray Inc.

Sunnyvale, Calif. • 408-716-4600 www.accuray.com

Exchange and Ticker: Nasdaq: ARAY

Filing Range: 7.33M shares @ $14.00 to $16.00

Offering Price: $18.00

Close on First Day: $28.47

Offering Size: $288M

Shares Outstanding: 52,212,444

Underwriters: JP Morgan/ UBS Investment Bank

Co-manager: Jefferies & Co. Inc.

Company Counsel: Latham & Watkins

Manager Counsel: Wilson Sonsini Goodrich & Rosati

Auditor: Grant Thornton LLP

Market Capitalization on 2/28/07: $1330.37M

Close price at current month end: $25.48

DESCRIPTION

Manufactures image-guided radiosurgery devices. The company’s core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer flexibility and accuracy. Accuray’s focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System. Competitors include Elekta AB, BrainLAB AG, Integra Life Sciences Holding Corp., Siemens AG, Varian Medical Systems, Inc. and TomoTherapy Inc.

VENTURE BACKERS

Marubeni Corp.